These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37702877)

  • 1. Predictive biomarkers for the early detection and management of heart failure.
    Mariappan V; Srinivasan R; Pratheesh R; Jujjuvarapu MR; Pillai AB
    Heart Fail Rev; 2024 Mar; 29(2):331-353. PubMed ID: 37702877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in heart failure: the past, current and future.
    Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F
    Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs.
    Shrivastava A; Haase T; Zeller T; Schulte C
    Front Cardiovasc Med; 2020; 7():601364. PubMed ID: 33330662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology.
    de Boer RA; De Keulenaer G; Bauersachs J; Brutsaert D; Cleland JG; Diez J; Du XJ; Ford P; Heinzel FR; Lipson KE; McDonagh T; Lopez-Andres N; Lunde IG; Lyon AR; Pollesello P; Prasad SK; Tocchetti CG; Mayr M; Sluijter JPG; Thum T; Tschöpe C; Zannad F; Zimmermann WH; Ruschitzka F; Filippatos G; Lindsey ML; Maack C; Heymans S
    Eur J Heart Fail; 2019 Mar; 21(3):272-285. PubMed ID: 30714667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biomarkers for the diagnosis and management of heart failure: natriuretic peptides].
    Castiglione V; Vergaro G; Aimo A; Prontera C; Musetti V; Masotti S; Battaglia D; Di Cecco P; Emdin M; Passino C
    G Ital Cardiol (Rome); 2021 Apr; 22(4):292-300. PubMed ID: 33783449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of miR-197-5p, a Circulating Biomarker for Heart Failure, with Myocardial Fibrosis and Adverse Cardiovascular Events among Patients with Stage C or D Heart Failure.
    Liu W; Zheng J; Dong J; Bai R; Song D; Ma X; Zhao L; Yao Y; Zhang H; Liu T
    Cardiology; 2018; 141(4):212-225. PubMed ID: 30836355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.
    Buglioni A; Burnett JC
    Clin Chim Acta; 2015 Mar; 443():3-8. PubMed ID: 25445413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for the diagnosis and management of heart failure.
    Castiglione V; Aimo A; Vergaro G; Saccaro L; Passino C; Emdin M
    Heart Fail Rev; 2022 Mar; 27(2):625-643. PubMed ID: 33852110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic potential of a circulating miRNA model associated with therapeutic effect in heart failure.
    Qian L; Zhao Q; Yu P; Lü J; Guo Y; Gong X; Ding Y; Yu S; Fan L; Fan H; Zhang Y; Liu Z; Sheng H; Yu Z
    J Transl Med; 2022 Jun; 20(1):267. PubMed ID: 35690861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of heart failure: advances in omics studies.
    Chi K; Liu J; Li X; Wang H; Li Y; Liu Q; Zhou Y; Ge Y
    Mol Omics; 2024 Mar; 20(3):169-183. PubMed ID: 38224222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor 15 in heart failure: an update.
    Wollert KC; Kempf T
    Curr Heart Fail Rep; 2012 Dec; 9(4):337-45. PubMed ID: 22961192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure.
    Cruz MS; da Silva AMG; de Souza KSC; Luchessi AD; Silbiger VN
    Heart Fail Rev; 2020 Mar; 25(2):321-329. PubMed ID: 31254148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-seq driven expression and enrichment analysis to investigate CVD genes with associated phenotypes among high-risk heart failure patients.
    Ahmed Z; Zeeshan S; Liang BT
    Hum Genomics; 2021 Nov; 15(1):67. PubMed ID: 34774109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in the Management of Heart Failure.
    Kalampogias A; Siasos G; Oikonomou E; Mourouzis K; Bletsa E; Stampouloglou PK; Katsianos E; Vlasis K; Marinos G; Charalambous G; Vavouranakis M; Tousoulis D
    Curr Med Chem; 2021; 28(24):4863-4876. PubMed ID: 33602070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure in patients with kidney disease.
    Tuegel C; Bansal N
    Heart; 2017 Dec; 103(23):1848-1853. PubMed ID: 28716974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical adoption of prognostic biomarkers: the case for heart failure.
    Kalogeropoulos AP; Georgiopoulou VV; Butler J
    Prog Cardiovasc Dis; 2012; 55(1):3-13. PubMed ID: 22824105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--.
    Iwanaga Y; Miyazaki S
    Circ J; 2010 Jul; 74(7):1274-82. PubMed ID: 20558890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).
    Seliger SL; Hong SN; Christenson RH; Kronmal R; Daniels LB; Lima JAC; de Lemos JA; Bertoni A; deFilippi CR
    Circulation; 2017 Apr; 135(16):1494-1505. PubMed ID: 28159799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature review.
    Marsh AM; Nguyen AH; Parker TM; Agrawal DK
    Can J Physiol Pharmacol; 2017 Mar; 95(3):253-259. PubMed ID: 28092162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.